Profil
Henrik Sandvad Rasmussen gründete Rasmussen Biotech & Pharma Consulting LLC. Derzeit ist Dr. Rasmussen Chief Medical Officer von Allakos, Inc. Dr. Rasmussen ist außerdem Mitglied des Vorstands von Renibus Therapeutics, Inc. und Neoprogen, Inc. In der Vergangenheit war Dr. Rasmussen President & Chief Executive Officer bei Rasmussen Biotech & Pharma Consulting LLC, Chief Medical Officer für Nabi Pharmaceuticals, Global Study Director bei Pfizer Central Research, Senior VP-Clinical Research & Regulatory Affairs bei Vernalis Ltd, Chief Medical Officer bei GenVec, Inc, Chief Medical Officer bei Alba Therapeutics Corp, Chief Medical & Scientific Officer bei ZS Pharma, Inc, Vice President, Head-Medical & Regulatory Affairs bei Novo-Nordisk Biochem, Inc. und Chief Medical Officer bei Altimmune, Inc. Henrik Sandvad Rasmussen promovierte an der Universität von Kopenhagen.
Aktive Positionen von Henrik Rasmussen
| Unternehmen | Position | Beginn |
|---|---|---|
Neoprogen, Inc.
Neoprogen, Inc. BiotechnologyHealth Technology Develops novel cell-based therapy for people who experience a heart attack | Direktor/Vorstandsmitglied | - |
Renibus Therapeutics, Inc.
Renibus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a clinical stage biopharmaceutical company that develops products for cardio, renal and metabolic diseases | Gründer | 01.01.2015 |
Ehemalige bekannte Positionen von Henrik Rasmussen
| Unternehmen | Position | Ende |
|---|---|---|
| ALLAKOS INC. | Technik-/Wissenschafts-/F&E-Leiter | 11.06.2021 |
| ZS PHARMA INC | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2016 |
Rasmussen Biotech & Pharma Consulting LLC | Vorstandsvorsitzender | 01.01.2012 |
Novo-Nordisk Biochem, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2009 |
Nabi Pharmaceuticals | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2007 |
Ausbildung von Henrik Rasmussen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Ligand UK Ltd.
Ligand UK Ltd. BiotechnologyHealth Technology Engages in research and development & sells pharmaceutical products | Health Technology |
GenVec, Inc.
GenVec, Inc. Pharmaceuticals: MajorHealth Technology Develops bio-pharmaceutical products | Health Technology |
Alba Therapeutics Corp.
Alba Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets pharmaceutical products | Health Technology |
ZS Pharma, Inc.
ZS Pharma, Inc. BiotechnologyHealth Technology Develops develop new treatments of kidney and liver diseases | Health Technology |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novo-Nordisk Biochem, Inc. | |
Altimmune, Inc. /Old/
Altimmune, Inc. /Old/ Medical/Nursing ServicesHealth Services Develops vaccines and other biological products | Health Services |
Nabi Pharmaceuticals | |
Allakos, Inc.
Allakos, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops innovative therapeutics which target immunomodulatory receptors for the treatment of allergic, inflammatory and proliferative diseases | Health Technology |
Rasmussen Biotech & Pharma Consulting LLC | |
Renibus Therapeutics, Inc.
Renibus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a clinical stage biopharmaceutical company that develops products for cardio, renal and metabolic diseases | Health Technology |
Neoprogen, Inc.
Neoprogen, Inc. BiotechnologyHealth Technology Develops novel cell-based therapy for people who experience a heart attack | Health Technology |
















